Trinity Life Sciences

“Embracing the potential of AI in portfolio management, Trinity is paving the way for smarter, more informed commercialization decisions in the life sciences industry,” said Leslie Orne, President and CEO of Trinity Life Sciences. “Our AI algorithm empowers companies to optimize investments and deliver innovation and value to patients with greater precision than ever before.” Read more in our latest news release: https://bit.ly/4jzoTyD 

“Value work in life sciences should be driven by both HEOR and Access mindsets—HEOR expertise ensures that the work is scientifically rigorous and rooted in evidence, and the Access point of view brings deep understanding of global payer decision motivation and nuance,” added Mary Fletcher-Louis, a Managing Director in Trinity Life Sciences’ Evidence, Value, Access & Pricing practice and Head of Trinity’s Value COE. “Trinity’s Value COE combines HEOR and Access approaches to create powerful, successful value propositions with context.”  Read more in our latest news release: https://bit.ly/4i9S4XX 

Headed to Asembia's ASX25 in Las Vegas on April 27 - May 1? So are Olivia P. and Kim Littlefield. Connect with them to learn more about participating in market research studies. Book an onsite meeting today: https://lnkd.in/edk-rN3u

We’re thrilled to announce an exciting expansion of our customer engagement partnership program. Watch the video below to learn more. View our list of current partners: https://bit.ly/3G5lauf Featured Trinity experts: Jeff Fusco & Nancy Phelan

“HTA agencies are beginning to include health equity considerations into their access recommendations,” explained Monica Martin de Bustamante, Senior Partner and Head of Advisory at Trinity Life Sciences. “An emerging role for Trinity’s Value COE is incorporating the work of the health equity team into access materials in a way that moves the needle for payers—reducing silos and increasing the impact of the organization’s work.” Read more in our latest news release: https://bit.ly/4i9S4XX

Trinity Life Sciences is excited to attend Asembia's ASX25 in Las Vegas, NV on April 27 - May 1. Connect with Andrew Gould, Arie Grunberg and Greg Berzolla to discuss opportunities to participate in pricing and market access research engagements or to explore options to collaborate with U.S. access experts. Book an onsite meeting with the team today: https://lnkd.in/eufMN75H 

Join Value, Access and Pricing experts Max Hunt, Mary Fletcher-Louis and Pinar Bilir as they delve into the emerging role of health equity considerations as a differentiator in value narratives for global HTA (Health Technology Assessment) submissions. Register now: https://bit.ly/4iuvUA9 

Trinity Life Sciences is excited to be part of Asembia's ASX25 in Las Vegas, NV on April 27 - May 1. Our team of experts will be in booth 2006 to network with market access and pharmacy leaders. Connect with us to explore opportunities to drive innovation and excellence in life sciences. Interested in participating in market research studies? Book an onsite meeting to learn more: https://lnkd.in/edk-rN3u Looking to discuss opportunities to participate in pricing and market access research engagements or to explore options to collaborate with U.S. access experts? Let's connect onsite: https://lnkd.in/eufMN75H

Mary Fletcher-Louis, Managing Director & Head of Trinity Life Sciences’ Value COE, was recently featured in an article published by Informa. The article discusses a recent comparison of HTA agency guidance by Trinity which found that NICE (UK) and the HTA agencies in Canada and Australia are actively asking manufacturers to include health equity perspectives in their submissions. NICE will soon be updating its methods for technology evaluation to formally incorporate evidence on health inequalities. Mary notes that, “My team and I are helping the industry to figure out when health equity is relevant, and then to communicate the health-equity related value in a way that is acceptable to health care payers.” Message Mary on LinkedIn if you would like to discuss your value strategy, incorporating equity-driven approaches.  

Trinity Life Sciences was honored to be a Magna Cum Laude Sponsor at this year's Bottom Line Massachusetts Annual Rise UP Dinner. It was a fantastic opportunity to join forces with leading companies from life sciences, consulting, finance and more, all united in our commitment to workforce development and education.   Representing Trinity at the event were Sarah Zeoli, Langa Bakhuluma-Ncube, MPH, Ameet S. and Abbey Tavernese. Our team left inspired by Bottom Line's dedication to student access and success programs, as well as their unwavering commitment to empowering underserved communities.   As we look to deepen our involvement, we encourage our network to learn more about the impactful work Bottom Line is doing to support the next generation of the workforce. For more information, please visit their website: https://lnkd.in/dijpMiM